Semaglutide belongs to a class of drugs called GLP-1 receptor agonists, while tirzepatide is a dual GLP-1 and GIP receptor agonist
Am J Kidney Dis 71(1):6574 Tonneijck L, Muskiet MHA, Smits MM, van Bommel EJ, Heerspink HJL, van Raalte DH et al (2017) Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment
P., Trujillo J
"Many people have more than one of these problems, and weight loss from GLP-1s can make them all betterno other medications can do that." On top of that, some research also shows positive effects on reducing alcohol intake, mood, and more in some individuals
They asserted that the the high clinical benefit rate from GLP-1RA therapy in our series raises a clarion call for rigorous, systematic investigation to define what the appropriate roles for such treatments in MCAS actually will be . Mast Cell Case Reports The case reports provided suggested these drugs can produce a wide range of benefits